Gynecologic Oncology: Phase 3 Publication of Efficacy & Safety Results Comparing Paclitaxel Micellar & Cremophor EL-Paclitaxel
This peer-reviewed manuscript was published in Gynecologic Oncology in February 2020. It reviews results from a multicenter, open-label, randomized Phase III trial evaluating the efficacy and safety of paclitaxel micellar (+carboplatin) compared to Cr-EL paclitaxel (+carboplatin) in recurrent platinum-sensitive ovarian, fallopian tube or peritoneal carcinoma. To read the full study report download the publication.
